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MHC antigens in interferon ' (IFN') receptor deficient mice: IFN7-
independent up-regulation of MHC class H in renal tubules. MHC class
II gene products in parenchyrnal cells, such as tubular epithelial cells in
kidney, may play a role in the regulation of autoimmune reactions.
Expression of MHC class II in renal tubular cells is normally very low, but
it increases considerably under various pathologic conditions. The pre-
dominant role of IFNy in up-regulation of MHC class II expression has
been demonstrated repeatedly. We tested the existence of alternative
pathways of MHC class II regulation using IFNy receptor-deficient
(IFNyR—/—-) mice. Mutant and wild type mice received 50 rg bacterial
endotoxin (LPS) i.p. Four days later the kidneys were removed for
immunofluorescence examination. In agreement with published results
LPS provoked an increase of immunoreactivity for MHC class I and MHC
class II in proximal tubules of wild type mice. While MHC class I
up-regulation was strictly IFNy receptor-dependent, up-regulation of
MHC II was still evident in mutant mice, although less than in wild type
mice. Since injection of IFNy induced proximal tubular MHC class II
expression in wild type mice but not in IFNyR—/— mice, an alternative
signaling pathway for IFNy does not seem to exist. Thus, up-regulation of
MHC class II expression in renal tubules does not necessarily require
IFNy. The markedly patchy pattern of immunofluorescence in
IFNyR—/— mice suggests that induction of MHC class II after LPS
injection may represent renal injury due to shock.
MI-IC class II gene products in professional antigen-presenting
cells, namely B cells, dendritic cells and macrophages, are in-
volved in host defense through presentation to T cells of antigens
from invading microorganisms [1]. Except for thymic epithelium
[2, 3] the function of MHC class II antigens in non-hematopoietic
cells, for instance renal epithelia, is still unclear. A role in host
defense is unlikely since those cells obviously do not migrate to
lymph nodes, may lack costimulatory molecules [4—6], and ex-
press very low levels of MHC class II antigen under normal
conditions [4, 7—101. Nonetheless renal tubular epithelial cells may
be capable of antigen presentation in vitro provided that MHC
class II has been induced by IFNy [6, 8, 9, 11]. A role of MHC
class II antigens in nonhematopoietic cells, including renal prox-
imal tubular cells, has been suggested in triggering of DTH
response [12], in inhibition of autoimmunity by anergy or deletion
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of autoreactive T cells [4, 6, 11] and in the initiation of autoim-
munity by activation of autoreactive T cells [4, 9, 13—16]. Induc-
tion of MHC class II in tubules is, however, not sufficient for
eliciting autoimmune inflammation in the kidney [171.
Investigations on factors inducing MHC class I and class II
expression in nonhematopoietic cells have mainly focused on
IFNY [18]. The availability of mouse mutants defective in the
signaling pathway for IFNy [19] provided an opportunity to
investigate the role of this cytokine in the regulation of MHC
expression in the kidney. We tested the role of IFNy in induction
of MHC class I and class II antigens following injection of LPS in
IFNy receptor deficient (IFNyR—I—) mice. A single intraperito-
neal injection of LPS provokes an increased production of IFNy
[11, 20]. Our data suggest that, while IFNY plays a role in the
regulation of MHC class I and class II, it is not absolutely required




Adult, 6- to 10-week-old female mice of the strain 129/SV, of a
homozygous IFNyR—/— strain derived from 129/SV [19] and of a
homozygous MHC class Il—I— strain derived from C57/B6 [21]
were kept under optimal housing conditions (OHC). The colonies
were free from the three routinely tested pathogens, Sendai virus,
coronavirus and M. pulmonis.
Genotype analysis
The genotypes of the mice were verified by PCR analysis of tail
DNA lysate according to standard protocols using the following
primers: 5'-CCCAIThFAGATCCTACATACGAAACATACGG-3'
(sense) and 5' -YflTCTGTCATCATGGAAAGGAGGGATA-
CAG-3' (antisense). The amplified products were subjected to
electrophoresis. On the wild-type allele, the primer amplifies a
190 bp fragment. On the disrupted allele, the amplification
encompasses the inserted neomycine resistent gene marker and,
therefore, results in an approximately 1300 bp amplification
product.
Antibodies
Rat anti-mouse CD14 serum was a gift from Dr. S. Yamamoto.
The other antibodies were rat anti-mouse monoclonals. M5/
1721
1722 Haas et at.' MHC class II in proximal tubule
114.15.2 against MHC class II antigen and M1/42
against MHC class I antigen were gifts from Dr. H. Hengartner.
Anti-LFA-1 was obtained from PharMingen (San Diego, CA,
USA) and anti-MHC class II antigen (I-A), clone P7/7, from
Serotec (Oxford, UK).
LPS treatment
Six mice were treated per experimental group. Fifty xg of LPS
from E. coli (serotype 0111:B4; Sigma, St. Louis, MO, USA),
dissolved in sterile isotonic saline, were injected intraperitoneally.
Control animals received saline alone. Twelve hours, 24 hours or
four days after the injection the kidneys were removed under
anesthesia with methoxyflurane and shock-frozen in isopentane
maintained at the temperature of liquid nitrogen.
Interferon y treatment
Mice received intraperitoneal injections of 15000 or 60000 units
of murine IFNy dissolved in saline at day 0, 1 and 2. Three
wild-type mice and three mutant mice were used for each dosage.
Six animals of each population received saline alone. At day 4 the
kidneys were removed under anesthesia with methoxyflurane and
shock-frozen in isopentane maintained at the temperature of
liquid nitrogen. Recombinant murine IFNy was a gift from Dr. L.
Ozmen (Hoffmann-Laroche, Basel, Switzerland).
Immunohistochemistiy
Sections of 6 xm thickness were cut on a cryostat and air-dried
for storage at —80°C. Fixation in acetone (10 mm at 4°C) was
performed just before the immunolabeling. After a rinse in
Tris-buffered saline (TBS) the sections were incubated for 16
hours at 4°C with the primary antibodies diluted in TBS. The
sections were then washed in TBS and incubated for one hour at
room temperature with Cy3-labeled goat anti-rat immunoglobulin
antibody diluted 1:200. After rinsing in TBS the sections were
mounted in Immu-mount (Shandon, Pittsburgh, PA, USA) and
examined with a laser scanner microscope.
Results
MHC class II in proximal tubule
Similar immunofluorescence patterns were obtained with two
different antibodies against MHC class II, produced by the rat
hybridoma clones M5/114 and P7/7, respectively. Figures 1 and 2
show data obtained with the former, since it yielded higher signal
intensities. In untreated wild type mice and in untreated
IFNyR—/— mice the tubular epithelium was negative in the
cortex and only weakly positive tubules were occasionally detected
in the outer stripe of the medulla. Generally, the fluorescence was
not homogeneous in the few positive tubular profiles, suggesting
that only single cells expressed the antigen (Fig. 2D). Strong
immunoreactivity was detected in interstitial cells, probably den-
dritic cells.
Injection of IFNy in wild type mice resulted in a widespread
expression of MHC class II (Fig. IB). Immunoreactivity in
proximal tubules was strong in the cortex and moderate in the
outer stripe of the medulla. It was weaker in other tubular
structures and in glomeruli. Induction of MHC class II was
distinctly less marked with daily doses of 15000 units than with
60000 units. In IFNy-treated IFNyR—/--- mice the distribution
pattern of immunolabeling was the same as in untreated mice.
Except for a few profiles in the outer stripe, proximal tubules were
negative (Fig. 1A).
Four days after injection of LPS, immunoreactivity with MHC
class II antibodies was strongly increased in proximal tubules
(Figs. I and 2). In wild type mice most proximal tubular profiles
were labeled in the outer stripe of the medulla and in the cortex.
The average intensity of immunofluorescence was higher in the
outer stripe than in the cortex, in which the pattern of labeling was
patchy. In IFNyR—/— mice immunoreactivity in the outer me-
dulla was similar as in wild type mice, but in the cortex it was
distinctly less. In both populations of mice there were marked
differences of labeling intensity between neighboring proximal
tubules. Likewise within one single profile of a proximal tubule
immunoreactivity often varied among neighboring cells, especially
in the outer medulla (Fig. 2). Besides proximal tubules, other
segments of the nephron were not labeled with MHC class II
antibodies after LPS injection. In MHC class II—/— mice the
MHC class II antibodies did not yield any signal either in
untreated controls or after LPS injection (not shown).
MHC class I in proximal tubule
In untreated animals (Fig. 3A) immunoreactivity for MHC class
I was detected in vessels and in scattered interstitial cells, probably
representing leukocytes. Few proximal tubules were weakly la-
beled in the wild type (not shown) but not in the IFNyR—/— mice.
In wild type mice injection of IFN7 provoked a widespread, strong
up-regulation of MHC class I immunoreactivity in proximal
tubules, in glomeruli and in endothelia of peritubular capillaries
as well as of vasa recta (not shown). IFNy had no effect on MHC
class I in IFNyR—/— mice. Four days after LPS injection immu-
nolabeling of proximal tubules in wild type mice was moderate to
strong in the cortex (Fig. 3C), whereas it remained undetectable
or weak in the outer medulla (not shown). In IFNyR—/— mice
proximal tubules remained unlabeled (Fig. 3B).
CD14 in proximal tubules
The distribution pattern of the LPS receptor CD14 in kidney
was similar in IFNyR—/— mice as in wild type mice, in controls as
well as in LPS-treated animals. In kidneys of untreated animals
interstitial cells, probably representing dendritic cells, displayed a
weak immunoreactivity (not shown). Twelve hours after injection
of LPS additional labeling was found in the brush border of the
proximal tubule. It was stronger in the outer stripe of the medulla
than in the cortex (Fig. 4A). The tubular immunoreactivity was no
longer detectable 24 hours after injection of LPS (Fig. 4B).
Discussion
The purpose of the present study was to assess the role of IFNy
in the regulation of expression of MHC class I and class H in renal
tubular cells by using IFN'yR—/— mice. The most striking finding
was that MHC class II antigen expression could be induced by
LPS injection in proximal tubules of mice lacking the IFNy
receptor. This is the first direct evidence of IFNy-independent
induction of MHC class II in a non-hematopoietic cell type in vivo.
Up-regulation of MHC class I, however, was clearly dependent on
IFNy in that model.
MHC class I is constitutively expressed in all cell types, however
at very variable levels [10]. MHC class II is constitutively ex-
pressed at high levels in B cells and dendritic cells [22], whereas it
is normally undetectable in other cell types. The expression of
Fig. 1. MHC class II immunoreactivity in kidneys of IFNyR—/— mice (A, C) and of wild-type mice (B, D) treated with IFNy (A, B) or LPS (C, D).
Untreated wild-type and mutant mice displayed similar immunoreactivity patterns as the IFNy-treated IFN7R—/—- mice (A). The approximate border
between outer stripe and inner stripe of the medulla is indicated by a dotted line. Some glomeruli are marked (g) in order to indicate the presence of
cortex on the section. Magnification: X 100
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Fig. 2. MHC class II immunoreactivity in renal cortex (A—C) and outer medulla (D—F). A, D. Untreated IFNyR—/— mice; untreated wild type mice display
the same labeling pattern; arrow points to a single labeled cell in a proximal tubule. B, E. LPS-treated IFNyR—/— mice. C, F. LPS-treated wild type
mice. The approximate border between outer stripe and inner stripe is indicated by a dotted line. G: glomerulus. Magnification x360
MHC class II may be up-regulated under various conditions in
parenchymal cell types of several tissues. This occurs in the kidney
in autoimmune diseases [9, 23, 24], in infection [8], during
rejection of allografts [25] as well as after application of toxic
agents like streptozotozin [26, 27],LPS [20, 28, 29] or HgCl2 [30].
IFN7 plays a major role in up-regulation of MHC class II in
renal tubular epithelial cells. This has been demonstrated by
culture with IFNy [6, 11, 12, 33, 34]. Likewise IFNy antibodies
inhibit the induction of MHC class II in renal tubular cells in vivo
[20, 28—30, 35, 36] as well as in vitro [37]. When MHC class I
expression was investigated in those studies it was found to
respond to IFNy in the same way as MHC class II in proximal
tubules [27, 28, 30, 32, 34—36]. A role of cytokines other than
IFNY in the regulation of MHC class II expression in renal tubular
injecting IFNy to rodents [8, 29, 31, 32] and by treating cells in cells has not been demonstrated so far [9].
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Fig. 3. MHC class I immunoreactivity in renal cortex. A. Untreated wild
type; untreated IFNyR—/-- display a similar labeling pattern. B. LPS-
treated IFNyR—/—. C. LPS-treated wild type. Arrows: arterioles; arrow-
heads: leukocytes; G: glomerulus. Magnification x 360
The lower levels of tubular MHC class I and class II antigen
upregulation by LPS in IFNyR—/— animals compared to the wild
type is compatible with the known role of IFNy in controlling the
expression of MHC antigens. This is particularly true for MHC
class I, the up-regulation of which was abolished by the deletion of
the IFNy receptor. However, LPS provoked a clear increase of
MHC class II immunoreactivity in IFNyR—/— mice. Two lines of
evidence indicate that the immunoreactivity represented MHC
class II antigens. First, two anti-MHC class II antibodies (clone
P7/7 and clone M5/1 14) recognizing different epitopes yielded the
same pattern of immunofluorescence. Second, there was no
immunoreactivity in tubules of MHC class Il-deficient mice after
LPS injection.
Induction of MHC class II antigen after LPS treatment in
IFNyR—/— mice was unexpected since in the same experimental
model anti-IFNy antibodies have been reported to block the
induction of MHC class I and class II antigens [28, 29]. It is
possible that an IFNy-independent pathway of induction of MHC
class II antigen exists, that is more efficient in the mouse strain
129/SV, compared to the strains used by others in similar exper-
iments. It may also be hypothesized that the deletion of the IFNy
receptor leads to an alternative pathway for regulation of MHC
class II. Absence of IFNy signaling might for instance drive the
cytokine pattern of T helper cells from Thi- towards Th2-type
response. However interleukin-4, the only typical Th2 cytokine
known to up-regulate MHC class II expression in hematopoietic
cell types [18], had no effect on tubular cells in culture [33]. In the
same study TNF was also without effect on MHC class II in
tubular cells.
To test whether induction by LPS treatment of MHC class II in
the IFNyR—/— mice might be due to IFNy acting via an
alternative, still unknown receptor, we treated mice with murine
recombinant IFNy. Since MHC class II was induced in the wild
type mice but not in the IFNyR—/— mice, tubular expression of
MHC class II in the mutant mice after LPS treatment seems to be
truly independent of IFNy. Differences among renal zones in the
tubular expression of MHC class II after stimulation with IFNy on
the one hand and with LPS on the other hand further support the
presumption that the induction by LPS is not mediated by IENy.
Indeed, after IFNy treatment, tubular MHC class II immunore-
activity was clearly higher in the cortex than in the outer stripe of
the medulla. An inverse pattern was observed after LPS injection.
Furthermore, after LPS, in contrast to IFNy treatment, the
intensity of immunofluorescence is very variable among proximal
tubules as well as among cells within one tubule. That patchy
pattern does not suggest a response to a systemic factor. It rather
resembles the pattern of tubular injury caused for instance by
hypoxia or toxic agents. Thus, LPS-induced up-regulation of
MHC class II in proximal tubule might be a consequence of renal
injury due to shock [38]. In that respect it is interesting that heat
shock and cadmium induce expression of MHC class II in
proximal tubular cells in vitro, possibly through HSP 70 [39]. In
wild type mice, the effect of LPS on MHC class II expression
might be a consequence of two independent events, namely on the
one hand renal injury and on the other hand the release of IFNy.
However, the lower level of tubular MHC class II immunofluo-
rescence in IFNyR—/— mice compared to wild type mice does not
necessarily reflect a direct role of IFNy in regulation of tubular
MHC class II expression after injection of LPS. The systemic
shock in response to LPS injection is much less in the mutant mice
[401. Thus, not only the levels of various cytokines, but also renal
function might be affected differently by LPS in the two popula-
tions of mice. Besides renal dysfunction due to shock, a direct
effect of LPS on proximal tubule seems possible since after LPS
injection the brush border displays transiently immunoreactivity
for the LPS receptor CD14. Tubular CD14 immunoreactivity was
found sixteen hours [41] and twelve hours (present study) after
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Fig. 4. CDJ4 immunoreactivity in kidneys of wild-type mice 12 hours (A) and 24 hours (B) after injection of LPS. The approximate border between outer
stripe and inner stripe is indicated by a dotted line. g: glomerulus. Magnification x 100
injection of LPS and it was undetectable after twenty-four hours.
The similarity in the distributions of MHC class II and of tubular
CD14 in LPS-treated mice, both being restricted to the proximal
tubule and both showing maximal levels in the outer stripe, is
compatible with an induction of MHC class II via direct interac-
tion of LPS with proximal tubular cells. The molecular weight of
the LPS-binding protein, which mediates the interaction of LPS
with CDI4, is about 60 kD. Thus it may be filtered in the
glomerulus and have access to CD14 at the brush border of the
proximal tubule. However, there exists to our knowlege no report
of a direct induction of MHC class II by LPS in any cell type.
In conclusion, the present observations in mice lacking the
IFNy signaling pathway suggest the existence of an IFNy-inde-
pendent pathway for upregulation of MHC class II in renal
proximal tubules. In contrast, IFNy seems to be required for
LPS-induced up-regulation of MHC class I. IFNyR—/— mice may
be useful for identification of cytokines or other signals involved
in IFNy-independent regulation of MHC H expression.
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